Immunoglobulin Products Market to grow at a CAGR of 10.11% during 2024-2028
The Immunoglobulin Products Market is expected to grow at a CAGR of 10.11% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 9699.84 million. The global immunoglobulin products market is experiencing significant growth, driven by advancements in biotechnology and manufacturing processes. These innovations enable the production of safer, more effective, and higher-quality therapies. Recombinant DNA technology and protein engineering are key biotechnological advancements, revolutionizing the production of immunoglobulin products through the creation of recombinant monoclonal antibodies and engineered antibody fragments. These next-generation immunoglobulin products offer enhanced therapeutic benefits, including increased potency, specificity, and reduced immunogenicity. Leading biopharmaceutical companies, including CSL Ltd., Takeda Pharmaceutical Co. Ltd., Grifols SA, and Octapharma AG, are at the forefront of utilizing these advancements to develop superior immunoglobulin therapies.
Get more information on Immunoglobulin Products Market by requesting a sample report
Technavio analysts predict that the IgG subsegment will lead the Product segment during 2024 and 2028 The IgG segment represents a substantial share of the global immunoglobulin products market, given the extensive application of IgG-based therapies in addressing immune-related conditions. IgG, the predominant antibody isotype in the human body, plays a pivotal role in immune response and pathogen defense. Derived from pooled human plasma donations, IgG products come in various formulations, including intravenous (IV), subcutaneous (SC), and intramuscular (IM) preparations. Key applications include primary immunodeficiencies, autoimmune diseases, neurological disorders, and select infectious diseases. Notable market participants in the IgG product segment include prominent pharmaceutical companies, such as CSL Limited.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish recent immunoglobulin product developments
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
The Immunoglobulin Products Market encompasses a range of therapeutic proteins derived from plasma, including those used to treat various primary immunodeficiency diseases such as Hypogammaglobulinemia and Agammaglobulinemia. These conditions result in a deficiency of immunoglobulins, which are essential proteins for the immune system. Plasma fractionation and plasma collection are crucial processes in the production of these immunoglobulin products. Immunoglobulin therapy, including Intravenous Immunoglobulin (IVIG), plays a significant role in managing conditions like Guillain-Barré Syndrome, Myasthenia gravis, Common Variable Immunodeficiency, and Immune thrombocytopenic purpura. IVIG, in particular, exhibits immunomodulatory and anti-inflammatory properties, making it an effective treatment for several diseases. Primary immunodeficiency diseases, such as SID, can be managed through regular IVIG therapy at clinics, hospitals, or even at home through homecare services. Additionally, IVIG is used in the treatment of HIV and other conditions, demonstrating its broad therapeutic applications. With advancements in technology and production methods, the Immunoglobulin Products Market is expected to grow significantly in the coming years.
According to Technavio, the global immunoglobulin products market is a segment of the larger global pharmaceuticals market, which encompasses entities involved in research and development (R&D) or manufacturing of various pharmaceutical offerings, including generic and non-generic drugs, veterinary drugs, and immunoglobulin products. The size of the global healthcare industry, which includes the revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is calculated by Technavio. Factors driving the growth of the global pharmaceuticals market include the increasing global population aging, with the proportion of those over 60 years old projected to rise significantly.
The Immunoglobulin Products Market is experiencing significant growth, fueled by the recent immunoglobulin product developments. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
